Current Value
$250.001 Year Return
Current Value
$250.001 Year Return
Double maintains 5 strategies that include PEN - Penumbra, Inc.
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ANAB | -0.02% | $665.47M | -5.39% | 0.00% |
| COR | -0.03% | $57.24B | +32.73% | 0.74% |
| GFI | 0.04% | $21.24B | +58.84% | 2.32% |
| CLLS | -0.07% | $111.75M | -18.42% | 0.00% |
| ATNI | -0.08% | $257.01M | -27.60% | 5.98% |
| VOD | -0.11% | $26.72B | +23.98% | 4.56% |
| BF.B | 0.14% | $13.17B | -34.44% | 3.20% |
| QNTM | 0.19% | $52.38M | +102.20% | 0.00% |
| HII | 0.23% | $9.66B | -0.47% | 2.18% |
| WBA | -0.28% | $9.95B | -0.69% | 4.36% |
| MNOV | -0.32% | $62.29M | -9.29% | 0.00% |
| IMMP | -0.32% | $240.96M | -12.23% | 0.00% |
| HRL | -0.32% | $16.88B | +0.49% | 3.72% |
| FL | 0.34% | $2.38B | +7.73% | 0.00% |
| EXC | 0.35% | $43.82B | +25.72% | 3.63% |
| MLYS | 0.36% | $892.90M | +13.32% | 0.00% |
| DFDV | 0.38% | $309.70M | +2,106.40% | 0.00% |
| FUBO | -0.38% | $1.29B | +187.79% | 0.00% |
| BF.A | 0.38% | $13.36B | -34.41% | 3.14% |
| SYPR | 0.51% | $46.42M | +9.19% | 0.00% |
Yahoo
Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2025 after market close on Tuesday, July 29, 2025 at 4:30 PM Eastern Time. A press release with second quarter 2025 financial results will be issued after market close that day.
SeekingAlpha
Thrivent Small Cap Stock Fund underperformed the Russell 2000 Index over the last quarter and the past year mainly due to security selection, somewhat offset by positive sector allocation.
SeekingAlpha
Penumbra: AI Meets Aspiration - Why The Stock Is A Structural Winner
Yahoo
ITGR vs. PEN: Which Stock Is the Better Value Option?
Yahoo
All Ruby XL system coils can be delivered through a 0.035-inch diagnostic catheter.
Yahoo
Penumbra’s first quarter saw robust demand across its U.S. thrombectomy business, a trend management attributed to continued physician adoption of proprietary CABT (computer-assisted blood clot thrombectomy) technology and the successful launch of new devices. CEO Adam Elsesser highlighted that clinical evidence supporting CABT’s benefits, especially in venous thromboembolism (VTE), drove significant conversion from traditional treatments. The strong product mix and operational efficiencies cont
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| BSX | 39.83% | $155.02B | +36.88% | 0.00% |
| BIO | 39.44% | $6.75B | -7.31% | 0.00% |
| ISRG | 39.34% | $192.83B | +22.60% | 0.00% |
| MMSI | 38.47% | $5.55B | +8.65% | 0.00% |
| EDIT | 38.35% | $188.35M | -50.44% | 0.00% |
| ROCK | 38.17% | $1.80B | -9.86% | 0.00% |
| TTMI | 37.42% | $4.13B | +108.74% | 0.00% |
| CVNA | 37.05% | $45.67B | +165.24% | 0.00% |
| BAM | 36.78% | $88.59B | +43.63% | 2.99% |
| JLL | 36.68% | $12.20B | +26.24% | 0.00% |
| AME | 36.27% | $42.26B | +10.21% | 0.64% |
| DOV | 36.25% | $25.52B | +5.20% | 1.11% |
| ADSK | 36.21% | $66.68B | +25.74% | 0.00% |
| TREX | 36.16% | $6.18B | -20.54% | 0.00% |
| TXG | 36.05% | $1.51B | -36.09% | 0.00% |
| SOFI | 36.04% | $19.50B | +173.49% | 0.00% |
| BLK | 35.62% | $163.33B | +33.60% | 1.96% |
| MCHP | 35.56% | $38.66B | -22.14% | 2.53% |
| NVST | 35.48% | $3.39B | +22.52% | 0.00% |
| ENOV | 35.46% | $1.89B | -26.15% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CNK | -14.50% | $3.46B | +40.52% | 0.53% |
| GO | -10.50% | $1.27B | -41.23% | 0.00% |
| KR | -9.94% | $47.17B | +41.48% | 1.81% |
| DG | -8.85% | $25.37B | -10.94% | 2.05% |
| TME | -7.79% | $13.46B | +33.33% | 0.95% |
| HSY | -7.16% | $35.62B | -4.79% | 3.11% |
| NERV | -6.11% | $11.68M | -45.78% | 0.00% |
| FYBR | -5.70% | $9.12B | +39.78% | 0.00% |
| BCE | -5.50% | $20.86B | -27.77% | 10.84% |
| VSTA | -5.31% | $341.66M | +42.00% | 0.00% |
| RRGB | -5.17% | $114.40M | -2.57% | 0.00% |
| NOC | -5.13% | $72.47B | +15.13% | 1.72% |
| PTGX | -4.86% | $3.11B | +45.16% | 0.00% |
| LTM | -4.60% | $12.31B | -95.54% | 2.46% |
| HRMY | -4.52% | $1.84B | +6.77% | 0.00% |
| BMBL | -4.40% | $703.41M | -29.36% | 0.00% |
| ED | -4.27% | $36.31B | +13.27% | 3.35% |
| NEUE | -4.10% | $61.16M | +29.25% | 0.00% |
| VSA | -4.03% | $8.76M | -18.25% | 0.00% |
| MED | -3.73% | $161.24M | -28.37% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IHI | 48.26% | $4.58B | 0.4% |
| XHE | 47.46% | $166.19M | 0.35% |
| FXH | 42.46% | $899.62M | 0.62% |
| QDVO | 42.15% | $80.14M | 0.55% |
| HEAL | 41.68% | $43.43M | 0.5% |
| PFUT | 39.41% | $376.77M | 0.65% |
| IMCG | 39.11% | $2.78B | 0.06% |
| PTH | 39.06% | $100.70M | 0.6% |
| IBUY | 38.28% | $150.79M | 0.65% |
| SNSR | 38.03% | $225.44M | 0.68% |
| FINX | 37.93% | $306.07M | 0.68% |
| PINK | 37.88% | $129.96M | 0.5% |
| FNY | 37.81% | $374.01M | 0.7% |
| VBK | 37.77% | $18.99B | 0.07% |
| VXF | 37.61% | $22.28B | 0.05% |
| FMDE | 37.47% | $2.82B | 0.23% |
| ISCG | 37.47% | $679.46M | 0.06% |
| MILN | 37.45% | $125.68M | 0.5% |
| FHLC | 37.30% | $2.43B | 0.084% |
| NUSC | 37.30% | $1.14B | 0.31% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -29.42% | $295.67M | 1.43% |
| TAIL | -26.54% | $99.49M | 0.59% |
| VIXY | -18.16% | $165.58M | 0.85% |
| FTSD | -17.49% | $231.68M | 0.25% |
| IVOL | -16.15% | $348.25M | 1.02% |
| XONE | -10.49% | $585.85M | 0.03% |
| STOT | -10.41% | $253.88M | 0.45% |
| KRBN | -10.39% | $162.64M | 0.85% |
| KCCA | -10.19% | $105.90M | 0.87% |
| AGZD | -10.04% | $102.60M | 0.23% |
| TBLL | -9.47% | $2.13B | 0.08% |
| TPMN | -9.24% | $30.70M | 0.65% |
| WEAT | -8.24% | $117.67M | 0.28% |
| USDU | -8.05% | $163.19M | 0.5% |
| TFLO | -7.26% | $6.83B | 0.15% |
| CLIP | -6.80% | $1.51B | 0.07% |
| UUP | -6.68% | $209.45M | 0.77% |
| SHYM | -6.28% | $354.58M | 0.35% |
| SPTS | -6.21% | $5.77B | 0.03% |
| BUXX | -5.26% | $324.81M | 0.25% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| SGOV | 0.08% | $49.73B | 0.09% |
| IBTK | -0.17% | $441.97M | 0.07% |
| IBTI | 0.18% | $1.06B | 0.07% |
| IEI | 0.29% | $15.41B | 0.15% |
| PSQA | -0.34% | $35.43M | 0.2% |
| NEAR | 0.35% | $3.34B | 0.25% |
| BILZ | -0.40% | $827.73M | 0.14% |
| ULST | 0.41% | $658.54M | 0.2% |
| GSY | 0.59% | $2.86B | 0.22% |
| AGZ | 0.62% | $613.46M | 0.2% |
| IBTJ | -0.71% | $684.86M | 0.07% |
| VRIG | 0.75% | $1.20B | 0.3% |
| BILS | 0.93% | $3.83B | 0.1356% |
| IBTH | -0.98% | $1.60B | 0.07% |
| BIL | -1.08% | $42.84B | 0.1356% |
| BSMR | 1.16% | $255.65M | 0.18% |
| JPST | 1.22% | $31.88B | 0.18% |
| SCHR | 1.32% | $11.10B | 0.03% |
| LGOV | 1.41% | $681.75M | 0.67% |
| STPZ | -1.41% | $450.05M | 0.2% |
